ENTITY
HealthCare Global Enterprises

HealthCare Global Enterprises (HCG IN)

88
Analysis
Health Care • India
HealthCare Global Enterprises is a leading healthcare provider in India, specializing in comprehensive cancer diagnosis and treatment, including medical oncology, radiation therapy, and surgical oncology. The company also offers fertility treatments under the Milann brand, advanced screening and diagnostic services, and multi-specialty hospital care. It was founded in 1989 (initially as Bangalore Institute of Oncology) and is headquartered in Bangalore, India.
more
•08 Oct 2022 02:14•Broker

Axis Top Picks - Oct 2022 - Earnings Commentary & Festival Demand to Drive the Market

Axis Top Picks basket delivered flattish returns (+0.2%) in a highly volatile Sep’22 which reported a rather mixed performance across sectors and...

Logo
407 Views
Share
•12 Apr 2022 17:23•Broker

Pharma Q4FY22 Preview: Cost Pressure and Pricing Erosion Compress Margins

We expect companies under our Pharma coverage to report high singledigit growth (6.2% YoY), primarily driven by Injectable and Generic segment.

Logo
402 Views
Share
•06 Oct 2025 20:17•Broker

Pick of the Week: Healthcare Global Enterprise Ltd - 04th October, 2025

HCG delivered a strong revenue beat with 16.7% YoY growth, supported by 257 new beds, a 15.7% rise in occupied bed days, and improved occupancy of 67%

Logo
258 Views
Share
•06 Aug 2025 05:20•Broker

Healthcare Global Enterprises Ltd - Growth Visible; Maintain BUY

The company reported EBITDA margins of 17.6%, down 50 bps QoQ but up 30 bps YoY. It reported EBITDA of 108 Cr, grew by 18.6% YOY and 2% QoQ.

Logo
206 Views
Share
•02 Jul 2025 00:52•Broker

Pick of the Week: Healthcare Global Enterprises Ltd - 28th June, 2025

HCG reported strong Q4FY25 results, with revenue growth of 18.3%, driven by a 3.5% YoY increase in ARPOB and ~16.7% growth in occupied days.

Logo
297 Views
Share
x